SCHEMBL19082418

SCHEMBL19082418

c1ccc2c(c1)ccc1c2sc2c(-c3c4ccccc4c(-c4ccc5oc6ccccc6c5c4)c4ccccc34)cc3c4ccccc4sc3c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.33
KDM4E B2RXH2 5/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 3/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.32
HPGD P15428 3/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
CYP1A1 P04798 2/20 0.31
CYP1B1 Q16678 2/20 0.31
CYP1A2 P05177 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945573 0.90 MAPT (0.35) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL19110306 0.87 ALOX5 (0.35) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL19082146 0.84 CYP1A1 (0.40) MAPTCYP1A1CYP1B1CYP1A2L3MBTL1
SCHEMBL19082421 0.84 PRKDC (0.34) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL17247148 0.84 KDM4E (0.37) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL17247187 0.84 KDM4E (0.37) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL19077543 0.83 ALOX5 (0.36) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL19082407 0.83 KDM4E (0.35) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL24518919 0.82 KDM4E (0.35) MAPTKDM4EKMT2AALDH1A1MEN1
SCHEMBL17945433 0.81 ALOX5 (0.44) MAPTKDM4EKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 MAPT 1294/4885KDM4E 3720/4885KMT2A 1773/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 MAPT 1294/4885KDM4E 3720/4885KMT2A 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.